Content area
Full Text
Icon has bought health research and commercialization company Mapi for integration into its existing commercialization team, a deal that bumped Icon’s whole-year revenue guidance to $1.77 billion on the upper end.
The addition of more than 700 Mapi employees, the majority of which works in real-world evidence and its analytics, will double Icon’s late-phase team. The combined team will continue to provide services in real-world evidence, health economics and market access, language services and strategic regulatory services.
The Irish CRO will also have access to Mapi Research Trust, a non-profit that collects patient-centered...